Location History:
- Lekgränd, SE (2001)
- Spånga, SE (2001 - 2015)
- Spanga, SE (1995 - 2017)
Company Filing History:
2 out of 2 
2 out of 2 
2 out of 2 
Years Active: 1995-2017
Title: Jan Bergman: Innovator in Pharmaceutical Formulations
Introduction
Jan Bergman is a notable inventor based in Spanga, Sweden. He has made significant contributions to the field of pharmaceuticals, holding a total of 14 patents. His work primarily focuses on innovative formulations that address various medical conditions.
Latest Patents
Among his latest patents is a pharmaceutical formulation comprising 2,3-dimethyl-6-(N,N-dimethylaminoethyl)-6H-indolo-(2,3-B)quinoxaline. This composition is designed for topical administration and is particularly useful for treating herpes virus infections of the skin or mucous membranes in mammals. Another significant patent involves thiol derivatives that exhibit antiviral activity, especially against the influenza virus. The compound (4-(2-chloro-4-nitrophenyl)piperazin-1-yl)(4-(2-fluoro-6-methoxyphenyl)-1-methyl-1H-1,2,3-triazol-5-yl)methanone is highlighted in this patent, along with methods for preparing these compounds.
Career Highlights
Jan Bergman has worked with various companies throughout his career, contributing his expertise to advance pharmaceutical innovations. His experience and knowledge have positioned him as a key figure in the development of effective antiviral treatments.
Collaborations
Throughout his career, Jan has collaborated with notable individuals such as Mohammed Homman and Lennart Möller. These partnerships have further enriched his work and contributed to the success of his inventions.
Conclusion
Jan Bergman is a distinguished inventor whose work in pharmaceutical formulations has made a significant impact in the medical field. His innovative approaches to treating viral infections demonstrate his commitment to advancing healthcare solutions.